We serve Chemical Name:N-(2-Methoxybenzyl)-2-propanamine CAS:756474-36-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-(2-Methoxybenzyl)-2-propanamine
CAS.NO:756474-36-9
Synonyms:Benzenemethanamine, 2-methoxy-N-(1-methylethyl)-;N-(2-Methoxybenzyl)-2-propanamine
Molecular Formula:C11H17NO
Molecular Weight:179.259
HS Code:2922299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:243.3±15.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.499
PSA:21.26000
Exact Mass:179.131012
LogP:2.31
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzenemethanamine, 2-methoxy-N-(1-methylethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2-Methoxybenzyl)-2-propanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenemethanamine, 2-methoxy-N-(1-methylethyl)- Use and application,Benzenemethanamine, 2-methoxy-N-(1-methylethyl)- technical grade,usp/ep/jp grade.
Related News: It also said it would bar South Koreans from visiting China as tourists. N-(2-Methoxybenzyl)-2-propanamine manufacturer The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. N-(2-Methoxybenzyl)-2-propanamine supplier It also said it would bar South Koreans from visiting China as tourists. N-(2-Methoxybenzyl)-2-propanamine vendor Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products. N-(2-Methoxybenzyl)-2-propanamine factory Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report.
